Akebia Therapeutics, Inc. (AKBA)
1.40
+0.03
(+2.19%)
USD |
NASDAQ |
Jan 22, 12:50
Akebia Therapeutics Free Cash Flow: 32.17M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Pfizer Inc. | 10.38B |
| Theravance Biopharma, Inc. | 243.48M |
| Zevra Therapeutics, Inc. | -24.23M |
| Organon & Co. | 598.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 28.10M |
| Cash from Investing (Quarterly) | -0.077M |
| Cash from Financing (Quarterly) | 1.113M |
| Free Cash Flow Per Share (Quarterly) | 0.1022 |
| Free Cash Flow to Equity (Quarterly) | 25.29M |
| Free Cash Flow to Firm (Quarterly) | 30.25M |
| Free Cash Flow Yield | 9.14% |